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EXECUTIVE SUMMARY

Background
Contraceptive use in Ghana has remained low despite its annual increase since 2012. The
annual increase has not been commensurate with the improvement in economic
indicators and the decline in total fertility rate (TFR) within the same period as anticipated.
Having a high unmet need for family planning (FP) (30% of married women and 40% of
unmarried sexually active women) suggests that there may be barriers to access and
uptake of FP. Over time, several policies, including Ghana’s Costed Implementation Plan
(CIP) from 2015 through 2020 have suggested several FP initiatives to improve
contraceptive use yet they have not been entirely implemented. Further, although FP was
included in the health insurance act passed in 2003 (Act 650), amended in 2008 (Act
753), and revised in 2012 (Act 852), which indicated that healthcare benefits include FP,
people continue to pay out of pocket for FP services at National Health Insurance Authority
(NHIA) credentialled facilities because the policy is yet to be implemented. In some
settings, evidence suggests an increase in contraceptive uptake with the implementation
of the removal of out-of-pocket (OP) costs for FP services, therefore, embedding an FP
package into Ghana’s national health insurance scheme may increase uptake of FP
service and method mix and improve health outcomes.

Objectives
The main objective of this study was to assess the impact of the FP Pilot intervention(s),
namely OP cost removal for FP services, demand generation for FP, and provider training
on long-acting reversible contraceptives (LARCs) service provision on FP service uptake.
Specifically, the study investigated:
i. The impact of the FP Pilot intervention(s) on the total number of new FP acceptors.
ii. The impact of the FP Pilot intervention(s) on method-specific new FP acceptors.

Methods
The study employed a quasi-experimental time-series design. The overall study period was
from January 2017 to February 2020 split into two phases: pre-intervention (January 2017
to April 2018), and intervention period (May 2018 to February 2020). The study used
monthly FP service data from Ghana Health Service’s District Health Information System
(DHIMS) for the assessment. Three different interventions were implemented—OP cost
removal for FP services, demand generation for FP, and provider training on long-acting
reversible contraceptives (LARCs) in the selected districts. The control districts were
selected based on their similarity to the intervention districts. Statistical analysis was
carried out by running controlled interrupted time series (ITS) models to assess the impact
of the different combinations of the interventions on total new FP service uptake and
method-specific uptake.
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Key findings
Impact of out-of-pocket cost removal for FP services and other interventions on uptake of
FP and method mix (all seven intervention districts with OP cost removal)
The difference in the number of new FP acceptors between intervention and control
districts in the first month of the intervention suggests a positive impact of the intervention
(but not statistically significant). Further, it was observed that pre-intervention, the total
number of FP acceptors in both the intervention and control districts were on the decline.
However, during the intervention period, the rate of increase in new FP acceptors in the
intervention districts trended higher compared to the control districts, but the differences
were not statistically significant. There was a statistically significant monthly increase in
new IUD acceptors throughout the intervention period in the intervention districts
compared with that of the control districts. Further, there was evidence that during the
intervention period, the intervention districts saw an increase in the number of new IUD
acceptors per month compared with the control districts where new IUD acceptors per
month decreased significantly over the same period. During the intervention period, new
oral contraceptive acceptors in both the intervention and control districts were on the
decline but not statistically significant.
Impact of out-of-pocket cost removal for FP services only on uptake of FP and method
mix
Prior to the intervention (out-of-pocket cost removal for FP services only), the number of
new FP acceptors was on a downward trend in both the intervention and control districts.
However, the impact of the intervention in the first month was positive, although not
statistically significant. Throughout the intervention period, new FP acceptors appeared to
be increasing in the intervention districts and decreasing in the control districts, although
neither was statistically significant. There was evidence that during the intervention period
the intervention districts increased in the number of new IUD acceptors. However, in the
control districts, the number of new IUD acceptors per month trended towards a decrease.
Also, it was observed that during the intervention period, the number of new oral
contraceptive acceptors in both the intervention and control districts was on the decline
although not statistically significant.
Impact of out-of-pocket cost removal of FP services, demand generation, and LARC
training on uptake of FP and method mix
The number of new FP acceptors in the intervention district significantly increased during
the intervention period. However, the increase in the control district, during the same
period was not statistically significant. With respect to IUD acceptors, there was a
statistically significant increase in the before- and during the intervention period trends in
the intervention district compared with the control district. After the introduction of the
intervention, new IUD acceptors in the intervention district increased monthly. Conversely,
the results showed that the number of new oral contraceptive acceptors in the intervention
and control districts trended downwards throughout the intervention period.
Impact of out-of-pocket cost removal for FP services and LARC training (without demand
generation) on uptake of FP and method mix
There was a statistically significant positive effect of the intervention during the first
month. The results also showed that after the first month, the number of new FP acceptors
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in the intervention district trended downwards, which was similar in the control district
although not statistically significant. For new IUD acceptors, there was limited evidence
that the intervention district was different from the control district pre-intervention and in
the first month of the intervention and similar results were found concerning oral
contraceptive acceptors.

Key recommendations
Based on the findings of the study, the following recommendations are made:
 The Ministry of Health in collaboration with the National Health Insurance Authority
and Ghana Health Service should strongly consider implementing the OP cost removal
for FP services as it increases the uptake of FP and method mix based on the positive
effect of OP cost removal for FP services on the number of new FP acceptors and
LARCs acceptors.
 The minimum package for the scale-up should be OP cost removal for FP services plus
demand generation activities based on the statistically significant effect of OP cost
removal for FP services on the number of new FP acceptors and LARCs acceptors.
 The Ministry of Health in collaboration with the National Health Insurance Authority
and Ghana Health Service should consider undertaking a needs assessment regarding
the capacity building of health providers for the provision of LARCs as the findings
showed an increase in the use of LARCs before scale-up.
 The Ministry of Health and Ghana Health Service should ensure FP commodity security
especially LARCs as there was evidence of an increase in LARCs acceptors.
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1

INTRODUCTION

1.1

Background

Although the rate of increase for contraceptive use in Ghana has grown at about three
percent annually since 20121, use rates remain lower than expected. Unmet need for
family planning (FP) remains high—30 percent of married and 42 percent of unmarried
sexually active women who want to avoid or delay pregnancy are not using FP2,3. To reduce
unmet need for FP, Ghana’s Costed Implementation Plan (CIP) for 2015 through 2020
recommended several FP interventions, including removal of direct cost barriers to FP
services to improve access. If the CIP recommendations had been fully implemented, more
than 2.3 million unintended pregnancies, 800,000 abortions, and 5,000 maternal deaths
between 2016 and 2020 could have been averted4. The burden of unintended
pregnancies, unsafe abortion, and maternal mortality fall most heavily on disadvantaged
populations such as adolescents, the poor, and rural residents5,6.
Out-of-pocket (OP) costs for FP, particularly for long-acting reversible contraceptives
(LARCs), can be a barrier to voluntary contraceptive uptake in high-, middle-, and lowincome countries. Evidence from studies of community-based programs that target
subsidies (e.g., vouchers) to potential FP clients have generally found an increase in FP
use7,8,9,10. Evidence of the magnitude of OP payments is clear from the 2018 Commodity
Gap Analysis commissioned by the Reproductive Health Supplies Coalition, which reported
that 80 percent of annual commodity costs in 135 low- and middle-income countries
(LMICs) were borne by consumers who bought FP supplies in the private sector11.
Subsidies, such as vouchers and health insurance, are often associated with lower OP
expenses for individuals accessing FP services, and the evidence suggest that these
strategies may accelerate gains in contraceptive prevalence and progress towards
universal health coverage (UHC)8,12,13. Embedding an FP package into national health
insurance may improve uptake of FP services.
In Ghana, the National Health Insurance Act was passed in 2003 (Act 650), amended in
2008 (Act 753), and revised in 2012 (Act 852), which indicated that healthcare benefits
include FP. The expectation was that about 800,000 women would be eligible to benefit
from FP inclusion in the National Health Insurance Scheme (NHIS)14. Although FP was

Ahmed S, Choi Y, Rimon JG, Alzouma S, Gichangi P, Guiella G, et al. 2019. Trends in contraceptive prevalence rates in sub-Saharan Africa since the 2012
London Summit on Family Planning: Results from repeated cross-sectional surveys. Lancet Glob Heal 19: 1-8.
https://linkinghub.elsevier.com/retrieve/pii/S2214109X19302001
2
Ghana Statistical Service, Ghana Health Service, ICF International. Ghana Health and Demographic Survey 2014. Rockville, Maryland, USA.
3
Ghana Statistical Service, Ghana Health Service, ICF. Ghana Maternal Health Survey 2017. The DHS Program: Rockville, Maryland, USA; 2018.
4
Government of Ghana. 2015. Accra: Ghana Health Service. 2015. Washington, DC: Futures Group, Health Policy Project. Ghana Family Planning Costed
Implementation Plan. www.familyplanning2020.org/sites/default/files/Ghana-Family-Planning-CIP-2016-2020.pdf
5
Ortayli N, Malarcher S. 2010. Equity Analysis: Identifying Who Benefits from Family Planning Programs. Stud Fam Plan 41(2): 101-108.
6
Ahmed S, Li Q, Liu L, Tsui AO. 2012. Maternal deaths averted by contraceptive use: an analysis of 172 countries. Lancet 380(9837): 111-125.
www.sciencedirect.com/science/article/pii/S0140673612604784
7
Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. 2010. The contraceptive CHOICE project: Reducing barriers to long-acting reversible
contraception. Am J Obs Gynecol 203(2).
8
Bellows B, Bulaya C, Inambwae S, Lissner CL, Ali M, Bajracharya A. 2016. Family Planning Vouchers in Low and Middle Income Countries: A Systematic Review.
Stud Fam Plan 47(4): 357-370.
www.researchgate.net/publication/310773977_Family_Planning_Vouchers_in_Low_and_Middle_Income_Countries_A_Systematic_Review
9
Goldin Evans M, Broyles S, Frederiksen B, Gee RE, Phillippi S, Sothern M, et al. 2019. Long-Acting Reversible Contraceptive Utilization After Policy Change
Increasing Device Reimbursement to Wholesale Acquisition Cost in Louisiana. Am J Obstet Gynecol.
https://linkinghub.elsevier.com/retrieve/pii/S0002937819305897
10 Eisenberg D, McNicholas C, Peipert J. 2013. Cost as a Barrier to Long-Acting Reversible Contraceptive Use in Adolescents. J Adoles Health 52 (4): S59-S63.
11 Reproductive Health Supplies Coalition. 2018. Global Contraceptive Commodity Gap Analysis 2018. Brussels.
12 Bellows B, Mackay A, Dingle A, Tuyiragize R, Nnyombi W. 2017. Increasing Contraceptive Access for Hard-to-Reach Populations with Vouchers and Social
Franchising in Uganda. Glob Heal Sci Pract 5(3): 446-455. https://doi.org/10.9745/GHSP-D-17-00065
13 Ross R, Fagan T, Dutta A. 2018. Is health insurance coverage associated with improved family planning access? A Review of Household Survey Data from
Seven FP2020 Countries.
14 FP2020. www.familyplanning2020.org/resources/advocacy-country-spotlight-ghana
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included in the health insurance Act, people continue to pay for FP products and services
at NHIA-credentialled facilities because the policy is yet to be implemented in practice.
Under the leadership of the Ministry of Health (MOH), the National Health Insurance
Authority (NHIA) in collaboration with the Ghana Health Service (GHS), Marie Stopes
International-Ghana (MSIG), and Population Council (the Council) started implementing a
pilot project to remove FP service OP cost. Under this pilot, all modern clinical FP methods
(e.g., injectable, implant, IUD, and sterilization) were added to the National Health
Insurance Scheme (NHIS) and expensed by facilities through the claims process. This
study seeks to assess the impact of the FP Pilot intervention on the uptake of FP services.

1.2

Study Objectives

The main objective of this study was to assess the impact of the FP Pilot intervention(s),
namely OP cost removal for FP services, demand generation for FP, and training on longacting reversible contraceptives (LARCs) methods on FP service uptake. Specifically, the
study investigated:
i.

The impact of the FP Pilot intervention(s) on the total number of new FP acceptors;
and

ii.

The impact of the FP Pilot intervention(s) on method-specific (IUDs, implants,
injectables, and oral contraceptives15) new FP acceptors.

1.3

Structure of the Report

The report is organized into four chapters. The introductory section (Chapter 1) presents
background information on the subject area, the problem of OP cost being a barrier to low
uptake of FP in LMICs as well as the importance of embedding an FP package into national
health insurance. The chapter also highlights the objectives of this study.
Chapter 2 outlines the methods used for the evaluation of the FP Pilot intervention. The
study design, the research setting (intervention and control districts), procedures used to
select study control districts, source of data, statistical analysis, and ethical guidelines are
presented in this chapter.
Chapter 3 presents the results on the impact of various combinations of the interventions
on FP service uptake between January 2017 and February 2020 in the various study
districts. The impact of OP cost removal for FP services and other interventions (all districts
with OP cost removal for FP services) on uptake of FP services and method mix is first
presented. Secondly, the impact of OP cost removal for FP services on uptake of FP and
method mix is presented. Thirdly, the impact of OP cost removal for FP services, demand
generation for FP services, and provider training on LARCs on uptake of FP services and
method mix is outlined. Lastly, the impact of OP cost removal for FP services and provider
training on LARCs on uptake and method mix are also presented.
Chapter 4 presents the summary of findings and Chapter 5 presents the conclusions and
recommendations of the study.

The FP Pilot intervention did include oral contraceptives, however, it is anticipated that the FP Pilot intervention activities (i.e., awareness creation activities,
demand generation, and provider training can influence the uptake of other FP methods such as oral contraceptives)
15
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2

METHODS

2.1

Design

A quasi-experimental times series design, using monthly FP service data from January
2018 to February 2020, was employed. The quasi-experimental times series design takes
the form:
Intervention Group
Control Group

O1 O2 O3 X O4 O5 O6
O1 O2 O3 - O4 O5 O6

Where:
Time
O
X

An observation measurement, the subscript is used to distinguish one
observation measurement from another.
Intervention(s) (i.e., the OP cost removal for FP services only intervention)

-

No intervention

2.2

Study Setting

This analysis was conducted for nine selected intervention and nine control districts in the
four FP Pilot intervention regions: Upper East, Ashanti, Central, and Volta (see Figure 1).
FIGURE 1: Map of study regions
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2.3

Selection of Study Districts

To reduce threats to validity, the control and intervention districts were as comparable as
possible based on the following criteria:
i. The intervention and control districts were in the same region but not contiguous;
ii. The proportions of rural localities within the intervention and control districts were
comparable;
iii. The structures of health facilities providing FP services in the intervention and control
areas were similar, e.g., if an intervention district had a hospital, the control district
also had at least one hospital;
iv. The total fertility rate (TFR) of intervention and control district pairs were similar; and
v. Proportions of women of reproductive age (WRA) were similar.
To further assess whether the selected intervention and control districts were similar,
principal component analysis (PCA) was used (in this case whether they fell into the same
group). The following variables were used for the PCA; the proportion of the district
described as rural, number of hospitals, number of health centers and clinics, number of
CHPS compounds (the lowest tier of health care provision in Ghana), TFR, and proportion
of WRA. The analysis included all study districts (88 districts) in the four regions where the
study took place: Ashanti, Central, Upper East, and Volta regions. Generally, the
intervention and control districts were similar, there were slight variations across a few
demographic and socioeconomic characteristics. Table 4 shows the list of the nine
intervention districts with the nine selected control ones.

2.3.1 Description of the Study Districts
Table 1 shows the demographic and socio-economic characteristics of the intervention
and control study districts. The nine districts exposed to the interventions were
Bolgatanga, Nabdam, Bawku West, Obuasi, Mfantiman, Ekumfi, Upper Denkyira East,
Upper Denkyira West, and Adaklu. These were matched to the following control districts
respectively: Bawku Municipality, Builsa South, Builsa North, Asante Akim Central, Agona
West, Agona East, Gomoa East, Assin South, and Akatsi North, which were not exposed to
the intervention(s). According to the 2010 Ghana Population and Housing Census, the
population of the intervention districts ranged from 33,826 (Nabdam) to 168,641
(Obuasi) while that of the control sites were from 29,777 (Akatsi North) to 207,071
(Gomoa East). Further, more than half of the districts were rural. Poverty incidence was
highest in Adaklu (89.7%) and lowest in Upper Denkyira West (3.3%). TFR ranged between
2.4 and 4.5 births per woman across the study districts. Again, across all districts, at least
seven out of 10 children ever born survived. In addition, women in their reproductive age
formed at least four in 10 of the population of females in the districts16.

16

Ghana Statistical Service, 2012; Ghana Poverty Mapping Report, 2015

4 | Research Report

TABLE 1: Matched FP Pilot intervention and control districts
Region

Number
(Match)

Upper
East

1

Ashant
i
Central

%
WR
A

Rura
l
Rura
l
Rura
l
Urba
n
Urba
n
Rura
l
Rura
l
Rura
l

3.
0
3.
6
3.
7
2.
7
3.
4
4.
0
3.
5
4.
5

50.
8
43.
4
42.
8
55.
7
49.
7
41.
2
50.
5
46.
2

80.2

89.7

Rura
l

2.
4

50.
3

89.3

98,538

42.0
84.4

2.
9
4.
3
3.
6
3.
2
3.
1
4.
0
3.
7
4.
3
4.
1

47.
8
45.
8
45.
8
42.
4
48.
3
45.
4
53.
0
44.
5
44.
3

83.4

36,514

Urba
n
Rura
l
Rura
l
Urba
n
Urba
n
Rura
l
Urba
n
Rura
l
Rura
l

Intervention
Bolgatanga

131,550

27.9

2

Nabdam

33,826

63.0

3

Bawku West

94,034

68.1

4

Obuasi

168,641

5.3

5

Mfantsiman

144,332

29.8

6

Ekumfi

52,231

48.4

7

Upper
Denkyira East
Upper
Denkyira
West
Adaklu

72,810

30.6

60,054

3.3

36,391

Volta

9

Upper
East

1

Volta

T
F
R

Poverty
Index

8

Ashant
i
Central

Rur
al/
Urb
an

Populati
on

District

2

Control
Bawku
Municipality
Builsa South

3

Builsa North

56,477

54.3

4

71,508

11.5

5

Asante Akim
Central
Agona West

115,358

4.4

6

Agona East

85,920

25.4

7

Gomoa East

207,071

14.5

8

Assin South

104,244

23.6

9

Akatsi North

29,777

26.5

% of Children
Surviving

77.9
78.5
88.7
83.3
78.6
84.9
85.8

78.9
79.1
88.0
82.7
84.1
85.2
84.8
80.9

Source: Ghana Statistical Service, 2012; Ghana Poverty Mapping Report, 2015
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2.4

The FP Pilot Intervention

In May 2018, under the leadership of the Ministry of Health (MOH), the National Health
Insurance Authority (NHIA) in collaboration with Ghana Health Service (GHS), Marie Stopes
International-Ghana (MSIG), and Population Council (PC) launched a pilot to include all
modern clinical FP methods (e.g., injectable, implant, IUD, sterilization) into the NHI
benefits package and expensed by facilities through the claims process. The five
organizations played complementary roles in the implementation of the FP Pilot project as
follows (Table 2):
TABLE 2: Roles of stakeholders in the FP Pilot Project
Organization
Ministry of Health
National Health Insurance
Authority
Ghana Health Service
Marie Stopes International
Ghana
Population Council

Role
To oversee the implementation of the pilot project
To lead the management of the implementation of
the pilot project
To coordinate the implementation of the pilot
project in health facilities and provider training on
LARCs service provision
To provide financial support and coordinating the
activities of the project
To undertake the evaluation of the intervention

The FP Pilot interventions were implemented in 158 public and private NHIA-credentialled
facilities across the nine intervention districts. Three different interventions were
implemented—OP cost removal for FP services, demand generation, and provider training
on long-acting reversible contraceptive (LARC) service delivery (Table 3). Five different
combinations of the three interventions were implemented in the nine districts:
i. OP cost removal for FP services + demand generation + LARCs training in one district;
ii. OP cost removal for FP services + LARCs training in one district;
iii. OP cost removal for FP services only in five districts;
iv. Demand generation only in one district; and
v. LARCs training only in one district.
In summary, the OP cost removal for FP services package was implemented in seven
districts, two districts had FP demand generation intervention, and in three districts,
selected providers were trained on LARCs insertion and removal. The pilot interventions
started in May 2018 and ended in July 2020.
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TABLE 3: Interventions implemented in the nine FP Pilot intervention districts
FP Pilot Districts
Intervent
Bolgatan Nabd
ion
ga
am
OP cost
removal
for
FP
services
LARCs
training
Demand
generati
on
Facilities

30

14

Baw
ku
West

27

Obu Mfantsim
asi
an

Eku
mfi

Adak
lu

Upper
Denky
ira
East

Upper
Denkyir
a West

14

12

13

25

11

12

Note: The FP Pilot intervention considered facilities that provide FP services and are credentialled
by NHIA; Upper Denkyira East and Upper Denkyira West were not included in the analysis for the
evaluation.

2.4.1 Description of the Interventions
Intervention 1: Removal of out-of-pocket costs of FP services
This was the primary intervention of the FP Pilot. It was implemented in seven districts
(Bolgatanga, Nabdam, Bawku West, Mfantsiman, Ekumfi, Obuasi, and Adaklu). In Ghana,
FP services are provided in both public and private healthcare facilities. Because, in
practice, FP is not fully covered under the NHIS benefit package, clients pay out-of-pocket
for FP services. The government of Ghana and its development partners procure FP
commodities (e.g., implants, IUDs, injectables, etc.) and through the Ghana Health Service
distribution channels, these commodities are distributed to public and private facilities.
Hence, the OP fee paid by clients does not include the cost of commodities but are fees
meant to cover the cost of consumables for providing the service, transportation,
distribution, and storage of commodities. The FP Pilot, therefore sought to remove OP
payment by asking credentialled public and private healthcare providers to provide clinical
FP methods (vasectomy, bilateral tubal ligation, implants, IUDs, and injectables) to NHIS
insured clients and complete the claims forms for submission and reimbursement.
Intervention 2: LARCs training in selected facilities in pilot and control districts
This was an additional intervention implemented in three districts (Bolgatanga, Adaklu,
and Upper Denkyira East) where some providers received LARCs training. The three
districts were selected for two reasons. The first was that two of these districts (Bolgatanga
and Upper Denkyira East) were among the districts identified at the start of the pilot with
a significant lack of FP providers trained in LARCs service provision. The second reason
was to get a rural perspective of the effect of LARCs training on FP uptake, hence, the
inclusion of Adaklu district—a predominantly rural district. The LARCs intervention trained
selected community health nurses (CHNs) and midwives lacking formal training in LARCs
service provision. The selection of participants was based on a LARCs needs assessment
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in the provider baseline survey that identified skills gaps for implant and IUD insertion and
removal. Due to resource and time constraints, the LARCs training intervention could not
include all CHNs and midwives lacking implant and IUD insertion and removal in the 3
districts. Instead, the training selected some of the untrained staff per district so that,
most, if not all health centers and the district hospitals had at least one FP service provider
trained and capable of providing LARCs. Table 4 presents the distribution of midwives and
CHNs by district.
TABLE 4: Number of CHNs and Midwives Training Needs Gap
District

Midwives

CHNs

Total
numb
er

Numb
er
traine
d in
LARCs

Number
untrain
ed in
LARCs

Numb
er
traine
d in
LARCs
for the
pilot

Total
numb
er

Numb
er
traine
d in
LARCs

No.
untrain
ed in
LARCs

Numb
er
traine
d in
LARCs
for the
pilot

Bolgatan
ga

80

52

28

10

140

67

73

15

Adaklu

13

3

10

10

40

5

35

15

Upper
Denkyira
East

12

1

11

10

62

38

24

15

Total

30

45

Intervention 3: Demand generation for FP
The third intervention, demand generation, was implemented in two districts (Bolgatanga
and Upper Denkyira West). These districts were selected based on the generally low state
of awareness on FP issues (e.g. unaware of FP importance in family wellbeing, high
prevalence of myths and misconceptions) identified at the start of the project. The demand
generation component of this intervention included education activities to address FP
myths and misconceptions through mass media and other campaigns.

2.5

Source of Data

Facility service data on uptake of FP and method mix were extracted from the District
Health Information Management System (DHIMS) database from January 2017 to
February 2020 for all the intervention and control districts (data was extracted on the 5th
February 2021). DHIMS is a nationwide health information data capture system that is
used to capture service data including FP.

2.6

Statistical Analysis for Evaluation

To assess the impact of the FP Pilot on FP service utilization, this study used two outcome
indicators 1) number of new FP acceptors, and 2) number of new FP acceptors by methods
(IUDs, implants, injectables, and oral contraceptives). As earlier indicated, the FP Pilot
considered clinical FP methods (e.g., injectable, implant, IUD, and sterilization). Hence,
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oral contraceptives were not included in the pilot intervention. However, it is anticipated
that the FP Pilot intervention activities such as awareness creation (implemented in all
intervention districts), demand generation (in selected districts), and provider training (in
selected districts) could have influenced the uptake of other FP methods such as oral
contraceptives. The overall study period was from January 2017 to February 2020 split
into two phases: pre-intervention (January 2017 to April 2018), and intervention (May
2018 to February 2020). The evaluation data was limited to February 2020 because of
the onset of COVID-19 in March 2020 and its expected impact on FP service uptake. In
this report, we focus on the new FP acceptors indicator as it is an indicator that signifies
the potential of an intervention to draw new clients as well as increase in uptake of FP17.
The interrupted time series (ITS) approach was used to assess the impact of the
interventions. The controlled ITS (multiple-group analyses) was utilized. The use of the
control ITS requires similar comparison groups which are not exposed to the intervention
to analyze a before-after comparison and an intervention-control comparison. The benefit
of this design is that it helps control for history bias due to time-varying confounders, in
particular co-interventions and other events concurrent with the intervention. Series of
controlled ITS segmented ordinary least square regression models were estimated, one
for each of the two indicators across the different combinations of the interventions using
the onset month of the FP Pilot interventions (May 2018) as the event. The analyses were
done using the Prais–Winsten method18. The analyses also took into consideration the
potential effect of seasonality in FP service utilization on the outcome variables. The
controlled ITS regression model takes the form:
𝑌𝑡 = 𝛽0 + 𝛽1 𝑇𝑡 + 𝛽2 𝑋𝑡 + 𝛽3 𝑋𝑡 𝑇𝑡 + 𝛽4 𝑍 + 𝛽5 𝑍𝑇𝑡 + 𝛽6 𝑍𝑋𝑡 + 𝛽7 𝑍𝑋𝑡 𝑇𝑡 + 𝜀𝑡 ----------(2)
Where 𝑌𝑡 is the aggregated outcome variable measured at each equally spaced time point
𝑡. 𝛽0 represents the intercept or starting level of the outcome variable (estimated number
of FP acceptors at the beginning of the pre-outbreak period). 𝛽1 estimates the average
monthly change in the number of FP acceptors until the introduction of the intervention
(COVID-19). 𝑇𝑡 is the time since the start of the study, 𝛽2 represents the change in the
level of service use that occurred in the period immediately following the introduction of
the intervention (compared with the counterfactual), 𝛽3 represents the difference between
the trend in FP service use pre-COVID-19 (preintervention) and during COVID-19 (during
intervention) periods. 𝑋𝑡 is a dummy (indicator) variable representing the intervention
(preintervention periods 0, otherwise 1), 𝑋𝑡 𝑇𝑡 is an interaction term and 𝜖𝑡 the random
error term.
Further, 𝑍 is a dummy variable denoting the cohort assignment (treatment or control), and
𝑍𝑇𝑡 , 𝑍𝑋𝑡 , and 𝑍𝑋𝑡 𝑇𝑡 are all interaction terms among previously described variables. 𝛽4
represents the difference in the level (intercept) of the outcome variable between
treatment and controls prior to the intervention, 𝛽5 represents the difference in the slope
(trend) of the outcome variable between treatment and controls prior to the intervention,
𝛽6 indicates the difference between treatment and control groups in the level of the
outcome variable immediately following the introduction of the intervention, and 𝛽7
represents the difference between treatment and control groups in the slope (trend) of the
17
18

Bertrand, J., Magnani, R. J., & Rutenberg, N. (1994). Handbook of Indicators for Family Planning
http://www.cpc.unc.edu/measure/publications/ms-94-01.
Linden, A. (2015). Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata Journal, 15(2), 480–500.

Program

Evaluation.
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outcome variable after initiation of the intervention compared with pre-intervention. The
data was analyzed using Stata version 16.

2.7

Ethical consideration

Ethical approval was obtained from the Ghana Health Service Ethics Review Committee
and the Population Council Institutional Review Board. Permission was sought from the
Family Health Division of Ghana Health Service to use the DHIMs data.

2.8

Limitations

Conscious efforts were made to select the most appropriate comparison districts in the
design phase of the study, but it is possible that the selected comparison districts did not
serve as the most appropriate counterfactuals as other programs or policy changes may
have influenced the indicators of interest in the intervention or comparison districts
differently. This limitation notwithstanding, the statistical analyses are appropriate and
robust and allow for interpretation of the results to inform policy decision-making.
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3

RESULTS

The analyses were conducted in line with the combination of interventions that were
implemented to assess the impact of the interventions on uptake of FP and method mix.
The combination of interventions considered in this analysis are (also see Table 3):
i. OP cost removal for FP services + other interventions (all seven intervention districts
with OP cost removal);
ii. OP cost removal for FP services only (five intervention districts);
iii. OP cost removal for FP services + demand generation + LARCs training (one
intervention district); and
iv. OP cost removal for FP services + LARCs training (one intervention district).
Subsequent sections will assess each of the four different sets of interventions and their
impact on the number of new FP acceptors and method-specific new FP acceptors. For
each section, the analyses are presented in four parts:
i. Impact of the intervention(s) on new FP acceptors (total);
ii. Impact of the intervention(s) on new IUD acceptors;
iii. Impact of the intervention(s) on new implant acceptors;
iv. Impact of the intervention(s) on new injectable acceptors; and
v. Impact (unintended) of the intervention(s) on new oral contraceptive acceptors.
As it is done in standard reporting of multiple groups ITS, for each FP indicator we present
the intervention and control group comparison together and report on whether or not there
was:
 Any significant difference in the level of the outcome between treatment and control
districts at baseline;
 Any significant difference in the slope between intervention and control districts prior
to the intervention;
 A significant difference in the level between intervention and control in the period
immediately following intervention initiation;
 Any significant difference between intervention and control in the slope after
initiation of the intervention compared with pre-intervention period; and
 Long-term effect.
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3.1
Impact of Out-of-Pocket Cost
Removal for FP Services and Any
Other Intervention on Uptake of FP
and Method Mix (All Seven
Intervention Districts with OP Cost
Removal)

FIGURE 2: Trends in new FP acceptors (January 2017 –
February 2020)

This section examines the impact of OP
cost removal for FP services and other
interventions on new FP acceptors as
well as IUD, implant, injectable, and oral
contraceptive acceptors. This involves
all seven intervention districts with OP
cost removal for FP services compared
with seven corresponding control
districts.

3.1.1 Impact on New FP Acceptors
Table 5 shows findings of the impact of OP cost removal for FP services and any other
intervention on the number of new FP acceptors (intervention and control districts).
As shown in Table 5 and Figure 2, before the intervention, the number of new FP acceptors
in both the intervention and control districts was on the decline but declining at a higher
rate in the intervention districts (Coef. = -11.3; not significant). In the first month of the
intervention (May 2018) however, there was a positive effect on the number of new FP
acceptors in the intervention districts (Coef. = 64.4; not significant). The number of new
FP acceptors trended towards an increase in the intervention districts pre– and during the
intervention trend compared with that of control districts (Coef. = 22.4; not significant).
During the intervention period, the number of new FP acceptors in the intervention districts
increased at a rate of 9.3 (C.I. = -3.5, 22.1) women per month compared with the control
districts, which continued to trend downward (Coef. = -1.8) but both were not statistically
significant. Although the intervention (OP cost removal for FP services and other
interventions) did not appear to have a statistically significant effect on uptake of
contraception, it did show improvement in the intervention districts given that prior to the
intervention, the trend in the number of new FP acceptors was on the downward trend and
improved drastically during the intervention period.
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TABLE 5: ITS parameter estimates for monthly new FP acceptors – seven intervention
and control districts
Variable
Number of new FP acceptors (in control group) in
Jan. 2017 (β0)
Average monthly change in number of new FP
acceptors (in control group), Jan. 2017-Apr. 2018
(β1)
Change in level of FP acceptors (in control group)
in May 2018 (β2)
Change in trend in monthly number of FP
acceptors (in control group) between Jan. 2017Apr. 2018 compared to May 2018-Feb. 2020 (β3)
Difference in number of new FP acceptors
between intervention and control groups in Jan.
2017 (β4)
Difference in trend in monthly number of new FP
acceptors between intervention and control
groups from Jan 2017-Apr. 2020 (β5)
Difference in the change in level of new FP
acceptors between intervention and control
groups in May 2018 (β6)
Difference in change in trend in monthly number
of new FP acceptors between treatment and
control from Jan. 2017-Apr. 2018 compared to
May 2018-Feb. 2020 (β7)
Average monthly change in number of new FP
acceptors from May 2018-Feb. 2020 (in
intervention group)
Average monthly change in number of new FP
acceptors from May 2018-Feb. 2020 (in control
group)
Difference
rho
Durbin-Watson statistic (original)
Durbin-Watson statistic (transformed)

New FP
acceptors

95% C. I.

1084.6***

989.2,1179.9

-8.6

-29.6,12.3

-56.4

-225.8,113.0

6.8

-23.3,36.9

793.2***

556.2,1030.2

-11.3

-43.0,20.5

64.4

-169.5,298.4

22.4

-21.8,66.6

9.3

-3.5,22.1

-1.8

-12.8,9.1

11.1

-5.7,28.0

0.670
0.668
1.576

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017
to February 2020
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3.1.2 Impact on New IUD and Implant Acceptors
Table 6 presents results of the impact of OP cost removal for FP services and other
interventions on new IUD and implant acceptors (intervention and control districts).

New IUD Acceptors
Model M1 on Table 6 and Figure 3 show that comparing the intervention and control
districts, at baseline the difference in the number of new IUD acceptors was significant
(Coef. = 19.3; C.I. = 14.6, 24.1) with the intervention districts being higher than the control
districts. The difference in trend in new IUD acceptors between intervention and control
districts prior to the start of the intervention was statistically significantly different (Coef.
= -0.8; C.I. =-2.0, 16.3), showing that whereas the number of new IUD acceptors in the
intervention districts was trending downward, it was trending upward in the control
districts. Additionally, there was no statistically significant intervention effect during the
first month of the intervention. However, there was a positive statistically significant
monthly increase in the pre– and during the intervention trend in the intervention districts
compared with that of the controls of 1.9 new IUD acceptors (C.I. = 1.1, 2.7). Further, there
was evidence that during the intervention, the number of new IUD acceptors in the
intervention districts increased significantly at a rate of 0.9 new IUD acceptors per month.
But, in the control districts, new IUD acceptors per month was decreasing significantly at
a rate of 0.2 new IUD acceptors per month over the same period. The difference between
the intervention and control districts was 1.1 new IUD acceptors per month. The results
show that the intervention had a significant effect on the number of new IUD acceptors.
Although there was no immediate effect in the first month of the intervention (OP cost
removal for FP services and any other intervention), there appeared to be a significant
long-term positive impact on the number of new IUD acceptors.

New Implant Acceptors
Model M2 on Table 6 and visualized in Figure 4, show no statistically significant difference
in new implants acceptors between the intervention and control districts at baseline, in
the first month of the intervention, and during the intervention period. However, while the
trend in the intervention districts was gradually increasing during the intervention period
at a rate of 1.8 new implants acceptors (not significant) per month, in the control districts,
it was increasing at a rate of 1.2 new implant acceptors (not significant) per month. Even
though the intervention (OP cost removal for FP services and any other intervention) did
not have a significant effect on the uptake of implant acceptors, there appears to be some
marginal improvement during the intervention period.
FIGURE 4: Trends in new IUD acceptors
(January 2017 – February 2020)
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FIGURE 3: Trends in new implant acceptors
(January 2017 – February 2020)

TABLE 6: ITS parameter estimates for monthly new FP acceptors – seven intervention and
control districts
IUDs (M1)
Variable

Coef.

95% C. I.

Implants (M2)
Coef.

Number of new FP acceptors (in
control group) in Jan. 2017 (β0)

2.1

-0.6,4.8

Average monthly change in number
of new FP acceptors (in control
group), Jan. 2017-Apr. 2018 (β1)

0.1

-0.2,0.3

-4.0*

-7.9,0.0

Change in level of FP acceptors (in
control group) in May 2018 (β2)

0.7

-1.2,2.6

-14.5

-43.6,14.5

Change in trend in monthly number
of FP acceptors (in control group)
between Jan. 2017-Apr. 2018
compared to May 2018-Feb. 2020
(β3)

-0.3+

-0.5,0.0

5.2*

0.1,10.2

Difference in number of new FP
acceptors between intervention and
control groups in Jan. 2017 (β4)

19.3***

14.6,24.1

49.0

-25.7,123.7

-0.8**

-1.4,-0.2

7.1

-2.0,16.3

Difference in the change in level of
new FP acceptors between
intervention and control groups in
May 2018 (β6)

-4.7

-12.3,2.8

-6.4

-77.4,64.5

Difference in change in trend in
monthly number of new FP
acceptors between treatment and
control from Jan. 2017-Apr. 2018
compared to May 2018-Feb. 2020
(β7)

1.9***

1.1,2.7

-6.6

-19.0,5.9

Average monthly change in number
of new FP acceptors from May
2018-Feb. 2020 (in intervention
group)

0.9***

0.5,1.3

1.8

-2.5,6.1

Average monthly change in number
of new FP acceptors from May
2018-Feb. 2020 (in control group)

-0.2***

-0.3,-0.1

1.2

-0.8,3.2

Difference

1.1***

0.7,1.5

0.5

-4.2,5.3

rho

0.478

0.640

Durbin-Watson statistic (original)

1.068

0.722

Durbin-Watson statistic
(transformed)

1.682

1.653

Difference in trend in monthly
number of new FP acceptors
between intervention and control
groups from Jan 2017-Apr. 2020
(β5)

270.4***

95% C. I.
223.7,317.0

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 to
February 2020
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3.1.3 Impact on New Injectable and Oral Contraceptive Acceptors
Table 7 presents findings of the impact of OP cost removal for FP services and other
interventions on new injectable and oral contraceptive acceptors (intervention and control
districts).

New Injectable Acceptors
Comparing intervention and control districts
(Model M1 on Table 7), there was no statistically
significant difference in the trend in the number
of new injectable acceptors pre-intervention.
However, from Figure 5, it is noticed that preintervention, new injectable acceptors in the
intervention and control districts showed a
downward trend, with the intervention districts
decreasing at a higher rate (Coef. = -9.9; not
significant).

FIGURE 5: Trends in new injectable acceptors
(January 2017 – February 2020)

Whereas there was no statistically significant
intervention effect during the first month of the
intervention, there was a marginal positive statistically significant monthly increase in the
pre– and during intervention trend in the intervention districts compared with that of the
controls of 17.4 new injectable acceptors (C.I. = -5.9, 40.7). From the results, during the
intervention period, the number of new injectable acceptors in the intervention districts
were increasing monthly at a rate of 5.2 new users per month and in the control districts,
decreasing at a rate of 2.2 new users per month (not significant) (Model M1 on Table 7
and Figure 5). From the results, the findings showed a marginal improvement in the
number of new injectable acceptors as there was an improvement in the intervention
districts during the intervention period.

New Oral Contraceptive Acceptors

FIGURE 6: Trends in new oral contraceptive

From Model M2 on Table 7, the difference in the
acceptors (January 2017 – February 2020)
slope between the intervention and control
districts pre-intervention was not statistically
significant (Coef. = -3.3). However, from Figure 6,
it is found that pre-intervention, the trend in the
number of new oral contraceptive acceptors was
decreasing in the intervention districts and
increasing in the control districts. Additionally,
there was no statistical evidence of the
intervention effect in the first month of the
intervention. Unlike pre-intervention, it is
observed that during the intervention period, new
oral contraceptive acceptors in both the intervention and control districts were on the
decline (not significant) but decreasing at a higher rate in the intervention districts
compared to the control districts (Figure 6). The findings did not show evidence of the
intervention having an unintended improvement in the uptake of oral contraception.
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TABLE 7: ITS parameter estimates for monthly new FP acceptors – seven intervention
and control districts
Injectables (M1)
Variable
Number of new FP acceptors (in control
group) in Jan. 2017 (β0)
Average monthly change in number of
new FP acceptors (in control group), Jan.
2017-Apr. 2018 (β1)
Change in level of FP acceptors (in control
group) in May 2018 (β2)
Change in trend in monthly number of FP
acceptors (in control group) between Jan.
2017-Apr. 2018 compared to May 2018Feb. 2020 (β3)
Difference in number of new FP acceptors
between intervention and control groups
in Jan. 2017 (β4)

Oral contraceptives
(M2)

Coef.

95% C. I.

Coef.

95% C. I.

598.6**
*

502.3,694.
8

65.1**
*

36.2,93.9

-8.9

-20.0,2.2

1.0

-2.2,4.3

-26.3

-79.0,26.4

-1.0

-23.0,21.0

6.7

-9.1,22.5

-3.0

-7.9,1.8

162.2,430.
7

38.5+

-1.7,78.8

296.4**
*

Difference in trend in monthly number of
new FP acceptors between intervention
and control groups from Jan 2017-Apr.
2020 (β5)

-9.9

-25.5,5.6

-3.3

-7.5,1.0

Difference in the change in level of new
FP acceptors between intervention and
control groups in May 2018 (β6)

11.2

-72.9,95.3

-2.5

-29.2,24.1

Difference in change in trend in monthly
number of new FP acceptors between
treatment and control from Jan. 2017Apr. 2018 compared to May 2018-Feb.
2020 (β7)

17.4+

-5.9,40.7

4.2

-1.8,10.3

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in intervention group)

5.2

-3.6,13.9

-1.0

-2.6,0.5

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in control group)

-2.2

-8.1,3.6

-2.0

-4.5,0.5

Difference

7.4

-3.1,17.9

1.0

-1.9,3.9

rho

0.768

0.703

Durbin-Watson statistic (original)

0.460

0.613

Durbin-Watson statistic (transformed)

1.235

1.542

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017
to February 2020
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3.2
Impact of Out-of-Pocket Cost Removal for FP Services Only on Uptake
of FP and Method Mix (Five Intervention Districts)
This section examines the impact of OP cost
removal for FP services on new FP acceptors, and
also on IUD, Implant, Injectable, and oral
contraceptive acceptors. This involves the five
intervention districts where OP cost removal for
FP services only was implemented compared with
the five corresponding control districts.

FIGURE 7: Trends in new FP acceptors
(January 2017 – February 2020)

3.2.1 Impact on New FP Acceptors
Table 8 presents results of the impact of OP cost
removal for FP services only on new FP acceptors
(intervention and control districts).
Comparing the intervention and control districts
(Table 8), new FP acceptors were significantly higher in the intervention districts compared
to the control districts at baseline (Coef. =839.6; C.I. = 604.9, 1074.3), however, the trend
over the pre-intervention period between the intervention and control districts was not
significantly different. The impact of the intervention in the first month appeared to be
positive, although not significant (Coef. 63.0; C.I. -145.1, 271.1). Worth noting however is
that unlike the pre-intervention downward trend in both intervention and control districts,
during the intervention period, new FP acceptors appeared to be increasing at a rate of
7.8 new FP acceptors in the intervention districts and continued on a declining trend in
the control districts at a rate of 1.5 new FP acceptors (not significant) (also Figure 7). The
impact of OP cost removal for FP services only appeared to have had a positive impact on
uptake of FP services as it showed noticeable improvement during the intervention period
(although not statistically significant).
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TABLE 8: ITS parameter estimates for monthly new FP acceptors – five intervention and
control districts
Variable
Number of new FP acceptors (in control
group) in Jan. 2017 (β0)
Average monthly change in number of new
FP acceptors (in control group), Jan. 2017Apr. 2018 (β1)
Change in level of FP acceptors (in control
group) in May 2018 (β2)
Change in trend in monthly number of FP
acceptors (in control group) between Jan.
2017-Apr. 2018 compared to May 2018Feb. 2020 (β3)
Difference in number of new FP acceptors
between intervention and control groups in
Jan. 2017 (β4)
Difference in trend in monthly number of
new FP acceptors between intervention and
control groups from Jan 2017-Apr. 2020 (β5)
Difference in the change in level of new FP
acceptors between intervention and control
groups in May 2018 (β6)
Difference in change in trend in monthly
number of new FP acceptors between
treatment and control from Jan. 2017-Apr.
2018 compared to May 2018-Feb. 2020
(β7)
Average monthly change in number of new
FP acceptors from May 2018-Feb. 2020 (in
intervention group)
Average monthly change in number of new
FP acceptors from May 2018-Feb. 2020 (in
control group)
Difference
rho
Durbin-Watson statistic (original)
Durbin-Watson statistic (transformed)

New FP acceptors

95% C. I.

771.6***

656.1, 887.0

-9.2

-27.1, 8.6

-34.7

-174.5, 105.2

7.7

-17.8, 33.3

839.6***

604.9, 1074.3

-10.9

-39.6, 17.8

63.0

-145.1, 271.1

20.2

-19.7, 60.1

7.8

-4.6, 20.3

-1.5

-11.6, 8.6

9.3

-6.7, 25.4

0.676
0.653
1.555

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017
to February 2020
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3.2.2 Impact on New IUD and Implant
Acceptors

FIGURE 8: Trends in new IUD acceptors
(January 2017 – February 2020)

Table 9 presents results of the impact of OP cost
removal for FP services only on new IUD and
implants acceptors (intervention and control
districts).

New IUD Acceptors
From Model M1 (Table 9) visualized in Figure 8,
the intervention and control districts were
significantly different at baseline. The trend over
the pre-intervention period between the
intervention and control districts was significantly
different (Coef. = -0.8; C.I. -1.4, -0.2), indicating
FIGURE 9: Trends in new implant acceptors
that the number of new IUD acceptors in the
(January 2017 – February 2020)
intervention districts was declining at a higher
rate compared to the control districts. There was
no statistically significant intervention effect
during the first month of the intervention (Coef. =
-3.6; C.I.=-10.9, 3.7). However, there was
evidence of an increase during the intervention
period in the intervention districts compared with
that of the controls by 1.7 new IUD acceptors.
Although not statistically significant, it appears
that during the intervention period, the number of
new IUD acceptors in the intervention districts
increased at a rate of 0.8 per month. In the control districts however, the number of new
IUD acceptors per month was decreasing by 0.1 per month though not significant. The
results showed a noticeable significant difference between the intervention and control
districts at baseline and the pre-intervention period, showing that uptake of IUD was
significantly declining in the intervention districts. However, in the intervention period,
there was an improvement in the uptake of IUD services, while uptake of IUD services
trended downward.
New Implant Acceptors
From Model M2 on Table 9 (also see Figure 9), the results show no statistically significant
difference in the number of new implant acceptors comparing the intervention with control
districts. However, while the trend in the intervention districts was increasing at a rate of
1.4 per month during the intervention period (not significant), in the control districts, new
implants acceptors were decreasing at a rate of 0.4 women per month (not significant).
The intervention (OP cost removal only) did not appear to have improved the uptake of
implants.
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TABLE 9: ITS parameter estimates for monthly new FP acceptors - five intervention and
control districts
IUDs (M1)
Variable

Coef.

Implants (M2)

95% C. I.

Coef.

95% C. I.

Number of new FP acceptors (in control
group) in Jan. 2017 (β0)

1.7

-1.1, 4.5

Average monthly change in number of
new FP acceptors (in control group), Jan.
2017-Apr. 2018 (β1)

0.0

-0.2, 0.3

-2.6*

-5.0, -0.2

Change in level of FP acceptors (in
control group) in May 2018 (β2)

0.3

-2.4, 3.1

-0.9

-17.6, 15.9

Change in trend in monthly number of FP
acceptors (in control group) between
Jan. 2017-Apr. 2018 compared to May
2018-Feb. 2020 (β3)

-0.1

-0.4, 0.2

2.2

-1.0, 5.4

18.7***

14.0,
23.4

56.2+

-3.2, 115.5

Difference in trend in monthly number of
new FP acceptors between intervention
and control groups from Jan 2017-Apr.
2020 (β5)

-0.8**

-1.4, -0.2

5.7

-2.1, 13.5

Difference in the change in level of new
FP acceptors between intervention and
control groups in May 2018 (β6)

-3.6

-10.9,
3.7

-23.2

-79.6, 33.2

Difference in change in trend in monthly
number of new FP acceptors between
treatment and control from Jan. 2017Apr. 2018 compared to May 2018-Feb.
2020 (β7)

1.7***

0.9, 2.5

-3.9

-14.9, 7.1

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in intervention group)

0.8

0.4, 1.2

1.4

-2.6, 5.5

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in control group)

-0.1

-0.2, 0.0

-0.4

-1.7, 1.0

Difference

0.9

0.5, 1.3

1.8

-2.4, 6.0

Difference in number of new FP
acceptors between intervention and
control groups in Jan. 2017 (β4)

167.0***

rho

0.529

0.681

Durbin-Watson statistic (original)

1.026

0.649

Durbin-Watson statistic (transformed)

1.724

1.600

136.9,
197.1

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 to
February 2020
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3.2.3 Impact on new Injectable and Oral
Contraceptive Acceptors

FIGURE 10: Trends in new Injectable acceptors
(January 2017 – February 2020)

Table 10 presents results of the impact of OP cost
removal only on new injectable and oral
contraceptive acceptors (intervention and control
districts).

New Injectable Acceptors
Comparing the intervention and control districts
(M1 on Table 10), prior to the intervention, the
trends in the number of new injectable acceptors
were declining in both the intervention and
control districts. During the intervention period
however, the number of new injectable acceptors
in the intervention districts showed an upward
trend, increasing at a rate of 4.5 new acceptors
per month, while the control districts continued to
decline at a rate of -0.6 new acceptors (not
statistically significant) (Figure 10). There is some
evidence, though not statistically significant to
show that the intervention (OP cost removal only)
did have a positive impact on injectable
acceptors as there was noticeable improvement
during the intervention period.

FIGURE 11: Trends in new oral contraceptive
acceptors (January 2017 – February 2020)

New Oral Contraceptive Acceptors
With respect to the number of new oral contraceptive acceptors, the intervention and
control districts (M2 on Table 10), new oral contraceptive acceptors were not significantly
different pre-and during the intervention period. However, it was observed that during the
intervention period, the number of new oral contraceptive acceptors in both the
intervention and control districts continued to decline although not statistically significant
(Figure 11).
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TABLE 10: ITS parameter estimates for monthly new FP acceptors – five intervention
and control districts
Injectables
Variable
Number of new FP acceptors (in control
group) in Jan. 2017 (β0)

Coef.
429.6***

95% C. I.

Oral contraceptives
Coef.

95% C. I.

325.0,
534.2

34.3***

22.3, 46.4

Average monthly change in number of
new FP acceptors (in control group),
Jan. 2017-Apr. 2018 (β1)

-9.9*

-19.0, -0.8

0.3

-1.5, 2.2

Change in level of FP acceptors (in
control group) in May 2018 (β2)

-25.5

-57.0, 6.0

-1.2

-13.2, 10.8

9.3

-2.4, 21.0

-1.4

-4.1, 1.3

172.7,
451.2

58.6***

Change in trend in monthly number of
FP acceptors (in control group)
between Jan. 2017-Apr. 2018
compared to May 2018-Feb. 2020 (β3)
Difference in number of new FP
acceptors between intervention and
control groups in Jan. 2017 (β4)

312.0***

30.0, 87.2

Difference in trend in monthly number
of new FP acceptors between
intervention and control groups from
Jan 2017-Apr. 2020 (β5)

-9.6

-23.4, 4.2

-2.3

-5.4, 0.8

Difference in the change in level of new
FP acceptors between intervention and
control groups in May 2018 (β6)

36.5

-31.0,
103.9

-4.7

-21.8, 12.4

Difference in change in trend in
monthly number of new FP acceptors
between treatment and control from
Jan. 2017-Apr. 2018 compared to May
2018-Feb. 2020 (β7)

14.7

-5.5, 34.9

2.3

-2.0, 6.7

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in intervention group)

4.5

-3.9, 12.9

-1.0

-2.5, 0.6

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in control group)

-0.6

-4.5, 3.4

-1.0

-2.1, 0.0

Difference

5.1

-4.2, 14.4

0.1

-1.8, 1.9

rho

0.778

0.734

Durbin-Watson statistic (original)

0.447

0.585

Durbin-Watson statistic (transformed)

1.196

1.638

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 to
February 2020

23 | Research Report

3.3
Impact of Out-of-Pocket Cost Removal for FP Services, Demand Generation,
LARC Training on Uptake of FP and Method Mix (one district)
This section examines the impact of OP cost removal for FP services, demand generation,
and LARCs training on new FP, IUD, implant, injectable and oral contraceptive (unintended)
acceptors. This involves only one intervention district where the three combinations of
interventions were implemented compared with the corresponding control district.

3.3.1 Impact on New FP acceptors
Table 11 shows results of the impact of the three
combinations of the interventions (OP cost
removal for FP services, demand generation, and
LARCs training) on new FP acceptors
(intervention and control districts).

FIGURE 12: Trends in new FP acceptors
(January 2017 – February 2020)

From Table 11 and Figure 12, the results show no
evidence of a difference between the intervention
and control districts with respect to the number
of new FP acceptors during the pre-intervention
period. However, the trend in the intervention
district was significantly increasing during the
intervention period at a rate of about 2.7 (C.I. = 1.2, 4.3; p<0.001) new FP acceptors. In
contrast, the increase in the control district, during the intervention period was marginal
(Coef. = 0.6) and not significant. Although the intervention (OP cost removal for FP
services, demand generation, and LARCs training) did not have an immediate effect, it
significantly improved uptake of FP during the intervention period.
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TABLE 11: ITS parameter estimates for monthly new FP acceptors – one district
Variable
Number of new FP acceptors (in control group) in Jan.
2017 (β0)

New FP acceptors

95% C. I.
181.9, 291.6

236.8***

Average monthly change in number of new FP
acceptors (in control group), Jan. 2017-Apr. 2018 (β1)

-0.5

-6.6, 5.6

Change in level of FP acceptors (in control group) in
May 2018 (β2)

-8.7

-47.0, 29.6

Change in trend in monthly number of FP acceptors (in
control group) between Jan. 2017-Apr. 2018 compared
to May 2018-Feb. 2020 (β3)

1.1

-6.6, 8.8

Difference in number of new FP acceptors between
intervention and control groups in Jan. 2017 (β 4)

-6.0

-62.1, 50.1

Difference in trend in monthly number of new FP
acceptors between intervention and control groups
from Jan 2017-Apr. 2020 (β5)

0.3

-6.1, 6.8

-19.9

-62.8, 23.0

1.8

-6.6, 10.1

2.7***

1.2, 4.3

Average monthly change in number of new FP
acceptors from May 2018-Feb. 2020 (in control group)

0.6

-1.8, 3.0

Difference

2.1

-0.8, 5.0

Difference in the change in level of new FP acceptors
between intervention and control groups in May 2018
(β6)
Difference in change in trend in monthly number of new
FP acceptors between treatment and control from Jan.
2017-Apr. 2018 compared to May 2018-Feb. 2020 (β7)
Average monthly change in number of new FP
acceptors from May 2018-Feb. 2020 (in intervention
group)

rho

0.634

Durbin-Watson statistic (original)

0.749

Durbin-Watson statistic (transformed)

1.626

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017
to February 2020
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3.3.2 Impact on New IUD and Implant Acceptors
Table 12 presents findings of the impact of the three combinations of interventions on
new IUD and implant acceptors (intervention and control districts).

New IUD Acceptors
FIGURE 13: Trends in new IUD acceptors
Comparing the intervention and control districts
(January 2017 – February 2020)
(M1 on Table 12), the number of new IUD
acceptors was on the decrease in the
intervention district and on the increase in the
control district before the intervention. While
there was no statistically significant effect of the
intervention during the first month, there was a
statistically significant increase in the number of
new IUD acceptors in the intervention period in
the intervention district compared with the
control district (Coef. = 0.2; C.I. = 0.0, 0.4; p <
0.05). After the intervention, new IUD acceptors
in the intervention district increased monthly at a rate of 0.2 new IUD acceptors, and this
was statistically significant (C.I. = 0.1, 0.3; p < 0.01), while there was no noticeable
increase in the control sites (Figure 13). The findings show evidence of improvement in
new IUD acceptors as it improved significantly in the intervention period.
FIGURE 14: Trends in new implant acceptors
(January 2017 – February 2020)

New Implant Acceptors

Results from Model M2 (Table 12), prior to the
intervention, the number of new implants
acceptors was on the increase in the control
district and decreasing in the intervention district.
Additionally, there was no statistically significant
effect of the intervention during the first month.
However, the results show that during the
intervention period, the trend of new implants
acceptors in the intervention district significantly
increased monthly at a rate of 1.5 (C.I. = 0.6, 2.4;
p < 0.01) new acceptors and increased monthly
at a rate of 2.2 (C.I. = 1.3, 3.1; p < .001) new
acceptors in the control district (Figure 14). From the results, there is some evidence of
improvement in the intervention district regarding the number of new implant acceptors
as it improved from a declining pre-intervention trend to an increasing trend during the
intervention period.
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TABLE 12: ITS parameter estimates for monthly new FP acceptors – one district
IUDs (M1)
Variable

Coef.

95% C. I.

Implants (M2)
Coef.

95% C. I.

Number of new FP acceptors (in control
group) in Jan. 2017 (β0)

0.4

-0.2, 0.9

57.5***

Average monthly change in number of
new FP acceptors (in control group), Jan.
2017-Apr. 2018 (β1)

0.0

-0.1, 0.1

-0.1

-1.7, 1.6

Change in level of FP acceptors (in control
group) in May 2018 (β2)

-0.5

-1.6, 0.6

-15.2+

-31.7, 1.4

Change in trend in monthly number of FP
acceptors (in control group) between Jan.
2017-Apr. 2018 compared to May 2018Feb. 2020 (β3)

0.0

-0.2, 0.1

2.2*

0.2, 4.3

Difference in number of new FP acceptors
between intervention and control groups
in Jan. 2017 (β4)

0.4

-1.0, 1.8

22.2**

6.5,
37.
9

Difference in trend in monthly number of
new FP acceptors between intervention
and control groups from Jan 2017-Apr.
2020 (β5)

0.0

-0.2, 0.1

-0.5

-2.4, 1.4

Difference in the change in level of new
FP acceptors between intervention and
control groups in May 2018 (β6)

0.4

-1.0, 1.8

13.0

-6.8,
32.
8

Difference in change in trend in monthly
number of new FP acceptors between
treatment and control from Jan. 2017Apr. 2018 compared to May 2018-Feb.
2020 (β7)

0.2*

0.0, 0.4

-0.2

-2.8, 2.3

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in intervention group)

0.2**

0.1, 0.3

1.5**

0.6, 2.4

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in control group)

0.0

0.0, 0.0

2.2***

1.3, 3.1

Difference

0.2**

0.1, 0.3

-0.7

-1.9, 0.5

rho

0.524

0.552

Durbin-Watson statistic (original)

0.749

0.994

Durbin-Watson statistic (transformed)

1.626

1.651

44.4,
70.
7

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017
to February 2020
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3.3.3 Impact on New Injectable and Oral Contraceptive Acceptors
Table 13 shows findings of the impact of the three combinations of the interventions on
new injectable and oral contraceptive acceptors (intervention and control districts).

New Injectable Acceptors
From Model M1 on Table 13, the intervention did
not have a statistically significant effect on new
injectable acceptors pre-and during the
intervention, comparing the intervention and
control districts. Although not significant, during
the intervention period, the number of new
injectable acceptors was increasing in the
intervention district (Coef. = 1.0; C.I. = -0.1, 2.1;
p < 0.1) and continued to decline in the control
district (Figure 15). In general, the intervention
did not appear to have a significant impact on the
number of new injectable acceptors.

New Oral Contraceptive Acceptors

FIGURE 15: Trends in new injectable acceptors
(January 2017 – February 2020)

FIGURE 16: Trends in oral contraceptive

acceptors (January 2017 – February 2020)
The results show that in the pre-intervention
period, the number of new oral contraceptive
acceptors was on the decline in the intervention
district and trending upwards in the control
district (not significant). During the intervention
period, the number of new oral contraceptive
acceptors in the intervention district decreased at
a rate of 0.1 acceptors per month (not
significant). In the control district, the number of
new oral contraceptive acceptors trended
downwards, decreasing at a rate of 0.8 new
acceptors per month (C.I. = -1.7, 0.1; p < 0.1)
(Figure 16). Despite the intervention (OP cost removal for FP services, demand generation,
and LARCs training), the number of new oral contraceptive acceptors trended downwards
in the intervention and control districts.
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TABLE 13: ITS parameter estimates for monthly new FP acceptors – one district
Injectables (M1)
Variable

Oral contraceptives (M2)

Coef.

95% C.I.

Coef.

151.3***

124.1, 178.5

23.6**

Average monthly change in number
of new FP acceptors (in control
group), Jan. 2017-Apr. 2018 (β1)

-0.3

-4.1, 3.5

0.2

-1.7, 2.0

Change in level of FP acceptors (in
control group) in May 2018 (β2)

5.3

-23.2, 33.9

1.3

-11.0,
13.
5

Change in trend in monthly number
of FP acceptors (in control group)
between Jan. 2017-Apr. 2018
compared to May 2018-Feb. 2020
(β3)

-0.9

-6.0, 4.3

-1.0

-3.5, 1.6

Difference in number of new FP
acceptors between intervention and
control groups in Jan. 2017 (β4)

-12.4

-40.2, 15.4

-13.4

-30.0, 3.3

0.8

-3.3, 4.8

-0.4

-2.3, 1.5

Difference in the change in level of
new FP acceptors between
intervention and control groups in
May 2018 (β6)

-31.8

-63.4, -0.2

-0.7

-13.4,
11.
9

Difference in change in trend in
monthly number of new FP
acceptors between treatment and
control from Jan. 2017-Apr. 2018
compared to May 2018-Feb. 2020
(β7)

1.4

-4.2, 7.0

1.1

-1.6, 3.7

Average monthly change in number
of new FP acceptors from May
2018-Feb. 2020 (in intervention
group)

1.0+

-0.1, 2.1

-0.1

-0.4, 0.1

Average monthly change in number
of new FP acceptors from May
2018-Feb. 2020 (in control group)

-1.2

-3.1, 0.8

-0.8+

-1.7, 0.1

Difference

2.2+

-0.1, 4.4

0.7

-0.3, 1.6

Number of new FP acceptors (in
control group) in Jan. 2017 (β0)

Difference in trend in monthly
number of new FP acceptors
between intervention and control
groups from Jan 2017-Apr. 2020
(β5)

rho

0.641

0.721

Durbin-Watson statistic (original)

0.697

0.556

Durbin-Watson statistic
(transformed)

1.530

1.246

95% C.I.
7.5,
39.
7
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Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017 to
February 2020

3.4
Impact of Out-of-Pocket Cost Removal for FP Services and LARCs
Training on Uptake of FP and Method Mix (one district)
This section examines the impact of OP cost removal for FP services and LARCs training
on new FP, IUD, implant, injectable, and oral contraceptive (unintended) acceptors. This
involves only one intervention district where OP cost removal for FP services and LARCs
training was implemented compared with the corresponding control district.

3.4.1 Impact on New FP Acceptors
Table 14 presents results of the impact of the two
combinations of the interventions (OP cost
removal for FP services and LARCs training) on
new FP acceptors intervention and control
districts).

FIGURE 17: Trends in new FP acceptors
(January 2017 – February 2020)

New FP Acceptors
From Table 14 and Figure 17, there was a
statistically significant positive effect of the
intervention on the number of new FP acceptors
during the first month of the intervention (Coef. =
26.9; C.I. = 1.1, 52.6; p < .05). However, the
results further show that during the intervention period, the number of new acceptors in
the intervention district decreased at a rate of 1.4 new acceptors per month (C.I. -2.3, 0.5; p<.01). Although there was a similar decline in the control district, it was not
statistically significant. The findings seem to suggest that in the first month of the
intervention, there was a significant improvement in FP uptake and subsequently declined.
This will require further investigation to better understand what may have caused the
number of new FP acceptors to decline during the intervention period.
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TABLE 14: ITS parameter estimates for monthly new FP acceptors – one district
Variable
Number of new FP acceptors (in control group) in Jan.
2017 (β0)
Average monthly change in number of new FP
acceptors (in control group), Jan. 2017-Apr. 2018 (β1)

New FP
acceptors
79.6***

95% C. I.
48.4, 110.9

1.0

-1.8, 3.9

-18.2+

-39.9, 3.5

-1.8

-5.8, 2.2

Difference in number of new FP acceptors between
intervention and control groups in Jan. 2017 (β4)

-43.0*

-75.7,-10.3

Difference in trend in monthly number of new FP
acceptors between intervention and control groups
from Jan 2017-Apr. 2020 (β5)

-0.7

-3.9, 2.5

26.9*

1.1, 52.6

0.1

-4.4, 4.5

-1.4**

-2.3, -0.5

Average monthly change in number of new FP
acceptors from May 2018-Feb. 2020 (in control group)

-0.8

-3.0, 1.4

Difference

-0.6

-3.0, 1.8

Change in level of FP acceptors (in control group) in
May 2018 (β2)
Change in trend in monthly number of FP acceptors (in
control group) between Jan. 2017-Apr. 2018 compared
to May 2018-Feb. 2020 (β3)

Difference in the change in level of new FP acceptors
between intervention and control groups in May 2018
(β6)
Difference in change in trend in monthly number of new
FP acceptors between treatment and control from Jan.
2017-Apr. 2018 compared to May 2018-Feb. 2020 (β7)
Average monthly change in number of new FP
acceptors from May 2018-Feb. 2020 (in intervention
group)

rho

0.570

Durbin-Watson statistic (original)

0.845

Durbin-Watson statistic (transformed)

1.570

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017
to February 2020
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3.4.2 Impact on New IUD and Implant
Acceptors

FIGURE 18: Trends in new IUD acceptors
(January 2017 – February 2020)

Table 15 shows findings of the impact of the two
combinations of the interventions (OP cost
removal for FP services and LARCs training) on
new IUD and implant acceptors (intervention and
control districts).

New IUD Acceptors
Model M2 on Table 15 shows that the
interventions did not have a significant effect on
new IUD acceptors when the intervention district
was compared with the control district (Figure
18). During the intervention, while the number of new IUD acceptors was decreasing
significantly at a rate of 0.1 (C.I. = -0.2, 0.0) per month in the control district, there was no
statistically significant change in the intervention district.

New Implants Acceptors

FIGURE 19: Trends in new implant acceptors

(January 2017 – February 2020)
Comparing the intervention and control districts
(M2 on Table 15), There was a statistically
significant difference between the intervention
and control districts at baseline with the control
district doing better (Coef. = -29.0; C.I. = -56.2, 1.8). The results show no evidence of positive
intervention effect during the first month (May
2018) of the intervention. However, during the
intervention period, the number of new implant
acceptors in the intervention district significantly
decreased at a rate of 1.3 (C.I. = -1.9, -0.7; p
<0.001), while in the control district the number
of implant acceptors decreased by 0.5 (C.I. = -1.0, 0.1; p <0.001) per month (Figure 19).
This requires further investigation to understand the decline in the number of new implant
acceptors during the intervention period.
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TABLE 15: Parameter estimates for monthly new FP acceptors – one district
IUDs (M1)
Variable

Coef.

Implants (M2)

95% C.I.

Coef.

95% C.I.

Number of new FP acceptors (in control
group) in Jan. 2017 (β0)

-0.1

-0.5, 0.3

45.7**

Average monthly change in number of
new FP acceptors (in control group), Jan.
2017-Apr. 2018 (β1)

0.0

-0.1, 0.1

-1.2

-2.9, 0.5

Change in level of FP acceptors (in control
group) in May 2018 (β2)

1.0

-0.4, 2.4

-1.5

-8.2,5.1

Change in trend in monthly number of FP
acceptors (in control group) between Jan.
2017-Apr. 2018 compared to May 2018Feb. 2020 (β3)

-0.1 +

-0.3, 0.0

0.7

-1.1, 2.6

Difference in number of new FP acceptors
between intervention and control groups
in Jan. 2017 (β4)

0.3

-0.5, 1.1

-29.0*

-56.2, -1.8

Difference in trend in monthly number of
new FP acceptors between intervention
and control groups from Jan 2017-Apr.
2020 (β5)

0.0

-0.1, 0.1

1.7

-0.6, 4.0

Difference in the change in level of new
FP acceptors between intervention and
control groups in May 2018 (β6)

-1.1

-2.8, 0.6

8.8

-3.8, 21.4

Difference in change in trend in monthly
number of new FP acceptors between
treatment and control from Jan. 2017Apr. 2018 compared to May 2018-Feb.
2020 (β7)

0.0

-0.2, 0.3

-2.5+

-5.3, 0.2

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in intervention group)

0.0

-0.1, 0.0

-1.3***

-1.9, -0.7

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in control group)

-0.1*

-0.2, 0.0

-0.5+

-1.0, 0.1

0.0

-0.1, 0.1

-0.8+

-1.6, 0.0

Difference
rho

0.658

0.661

Durbin-Watson statistic (original)

0.744

0.702

Durbin-Watson statistic (transformed)

1.734

1.345

20.1, 71.4

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017
to February 2020
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3.4.3 Impact on New Injectables and Oral
Contraceptive Acceptors
Table 16 presents findings of the impact of the
two combinations of the interventions (OP cost
removal for FP services and LARCs training) on
new injectable and oral contraceptive
(unintended) acceptors (intervention and control
districts).

FIGURE 20: Trends in new injectable acceptors
(January 2017 – February 2020)

New Injectables Acceptors
Comparing the intervention and control districts
(M1 on Table 16), there was a statistically
significant difference between the intervention
and control districts at baseline (Coef. = -5.4; C.I.
= -8.9, -0.2; p < 0.01). Before the intervention,
there was also a statistically significant difference
FIGURE 21: Trends in new oral contraceptive
acceptors (January 2017 – February 2020)
between the slope of the intervention and control
districts, with the control district having a higher
number of new injectables acceptors (Coef. = 0.9; C.I. = -1.6, -0.2; p < 0.01). The results
showed evidence of positive intervention effect
during the first month (May 2018) of the
intervention (Coef. = 9.3; C.I. = 1.4, 17.2; p <
0.05). During the intervention period, the number
of new injectables acceptors in the intervention
district significantly decreased at a rate of 0.5
new injectables acceptors per month (C.I. = -0.8,
-0.2; p < 0.05). Although the number of new
injectable acceptors in the control district was also decreasing but not significantly (Figure
20). While the intervention appeared to have a significant effect in the first month of the
intervention, it declined thereafter, which requires further investigation to understand the
decrease in trend.

New Oral Contraceptive Acceptors
From Model M2 on Table 16, the results show that the intervention did not have any
unintended significant impact on the number of new oral contraceptive acceptors
comparing the intervention to the control districts (Figure 21).
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TABLE 16: Parameter estimates for monthly new FP acceptors – one district
Injectables (M1)
Variable

Oral contraceptives
(M2)

Coef.

95% C. I.

Coef.

Number of new FP acceptors (in control
group) in Jan. 2017 (β0)

20.0***

17.3, 22.8

7.2**

Average monthly change in number of
new FP acceptors (in control group),
Jan. 2017-Apr. 2018 (β1)

1.2***

0.6, 1.7

0.6+

-0.1, 1.3

Change in level of FP acceptors (in
control group) in May 2018 (β2)

-9.2**

-16.1, -2.4

-2.7

-10.1, 4.8

Change in trend in monthly number of
FP acceptors (in control group) between
Jan. 2017-Apr. 2018 compared to May
2018-Feb. 2020 (β3)

-1.5**

-2.6, -0.4

-0.7

-2.2, 0.8

Difference in number of new FP
acceptors between intervention and
control groups in Jan. 2017 (β4)

-5.4**

-8.9, -2.0

-5.9*

-10.8, 1.1

Difference in trend in monthly number
of new FP acceptors between
intervention and control groups from
Jan 2017-Apr. 2020 (β5)

-0.9**

-1.6, -0.2

-0.6+

-1.3, 0.1

Difference in the change in level of new
FP acceptors between intervention and
control groups in May 2018 (β6)

9.3*

1.4, 17.2

3.1

-4.4, 10.7

Difference in change in trend in monthly
number of new FP acceptors between
treatment and control from Jan. 2017Apr. 2018 compared to May 2018-Feb.
2020 (β7)

0.8

-0.5,2.0

0.8

-0.7, 2.3

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in intervention group)

-0.5**

-0.8, -0.2

0.1

0.0, 0.2

Average monthly change in number of
new FP acceptors from May 2018-Feb.
2020 (in control group)

-0.3

-1.1, 0.4

-0.1

-1.2, 1.0

Difference

-0.1

-1.0, 0.7

0.2

-0.9, 1.3

rho

0.545

0.512

Durbin-Watson statistic (original)

0.872

0.979

Durbin-Watson statistic (transformed)

1.785

1.613

95% C. I.
2.5,
12.
0

Note: + p < .1; * p < .05; ** p < .01; *** p < .001; Source: Ghana DHIMS data, January 2017
to February 2020
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4

SUMMARY

The evaluation assessed the impact of the various combinations of interventions that were
implemented on the number of new FP acceptors and method-specific new FP acceptors.
The combinations of interventions considered in this analysis were:
i. OP cost removal for FP services + other intervention (all seven intervention districts
with OP cost removal for FP services);
vi. OP cost removal for FP services only (five intervention districts);
vii. OP cost removal for FP services + demand generation + LARCs training (one
intervention district); and
viii. OP cost removal for FP services + LARCs training (one intervention district).
Findings from the ITS analyses show that three of the four combinations of interventions,
in general, appeared to have positive impacts on uptake of FP services and method mix.
Except for OP cost removal for FP services and LARCs training only (without demand
generation) combination of the intervention, all the other combinations showed positive
impacts on the overall uptake of FP services as well as on method-specific uptake. There
was also evidence of an increase in the use LARCs and a decrease in the use of shortterm methods. The relative weakness of OP cost removal and LARC Training as an
intervention needs to be investigated further.
Summary table of the impact of the combinations of interventions on the various FP indicators
Indicator

OP cost
removal and
other
interventions
(all seven
intervention
districts with
OP cost
removal)

OP cost
removal only

OP cost
removal for FP
services,
demand
generation,
and LARCs
training

OP cost
removal and
LARCs
training

New FP acceptors

Positive impact

Positive
impact

Positive
impact+

No positive
impact

New IUD
acceptors

Positive
impact+

Positive
impact+

Positive
impact+

No positive
impact

New implant
acceptors

Positive impact

Positive
impact

Positive
impact+

No positive
impact

New injectable

Positive
impact+

Positive
impact

Positive
impact+

No positive
impact

New oral
contraceptive#

No positive
impact

No positive
impact

No positive
impact

Positive
impact

Note: + = Significant; # examined whether the intervention(s) had unintended effects on uptake of
oral contraceptives
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5

CONCLUSION AND RECOMMENDATIONS

4.1

Conclusion

This report presents an evaluation of the impact of the various combination of FP Pilot
intervention on FP service uptake and methods. Generally, the various combinations of
interventions appeared to lead to an increase in the uptake of new FP acceptors. Although
not statistically significant in some cases, it showed positive impacts in the first month of
the intervention and/or an increase in the number of new FP acceptors during the
intervention period compared to the pre-intervention period in the intervention district(s)
relative to the control district(s). In some cases, the results showed that the interventions
had a positive effect after the introduction of the intervention comparing the intervention
to the control districts.
However, there was no surge in uptake of contraceptives immediately after cost removal.
The increases were gradual and progressive. In effect, cost removal did not result in a
spike in service utilization that could potentially overwhelm the health system, as was
initially feared. This implies that cost and other resources could be planned accordingly to
expect a gradual increase in contraceptive use.
Further, there was evidence of the effect of the intervention showing an increase in the
number of new long-term methods acceptors, especially IUDs, and a decline in the use of
oral contraceptives, one of the most popular short-term methods. Overall, there appeared
to be a sustained decline in the use of short-term methods as more and more women
opted for long-term methods, mainly IUD. The need to expand the number of providers
with skills to provide long-term methods becomes critical.

4.2

Recommendations

Based on the findings of the study, the following recommendations are made:


The Ministry of Health in collaboration with the National Health Insurance Authority
and Ghana Health Service should strongly consider implementing the OP cost
removal for FP services as it generally increases the total number of new FP
acceptors and new LARC acceptors.



The minimum package for the scale-up should be OP cost removal for FP services
plus demand generation activities based on the statistically significant effect of OP
cost removal for FP services on the number of new FP acceptors and LARCs
acceptors.



The Ministry of Health in collaboration with the National Health Insurance Authority
and Ghana Health Service should consider undertaking a needs assessment
regarding the capacity building of health providers for the provision of LARCs as the
findings showed an increase in the use of LARCs before scale-up.



The Ministry of Health and Ghana Health Service should ensure FP commodity
security especially LARCs as there was evidence of an increase in LARCs acceptors.
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